drug · small molecule
HYDROCODONE BITARTRATE AND ACETAMINOPHEN
updated 5mo agoby $IGC IGC Pharma, Inc.🔗 ChEMBL
community read0 votes
🐶 often sniffed alongside
top 8- tagApproval7,790 co-mentions · 1766 sources
- tagSmall Molecule3,894 co-mentions · 1765 sources
- drugHYDROCODONE BITARTRATE AND IBUPROFEN1,611 co-mentions · 537 sources
- drugHYDROCODONE BITARTRATE1,611 co-mentions · 537 sources
- drughydrocodone bitartrate ER1,611 co-mentions · 537 sources
- drugcodeine1,153 co-mentions · 591 sources
- drugPROMETHAZINE HYDROCHLORIDE, PHENYLEPHRINE HYDROCHLORIDE W/CODEINE PHOSPHATE1,124 co-mentions · 562 sources
- drugPROMETH HYDROCHLORIDE,PHENYLEPHRINE HYDROCHLORIDE W/CODEINE PHOSPHATE1,124 co-mentions · 562 sources
Small molecule drug with a maximum clinical stage of Approval (across all indications), with 18 approved and 81 investigational indications.
targets
CyclooxygenaseFatty-acid amide hydrolase 1Transient receptor potential cation channel subfamily V member 1
all catalysts(0)
nothing on the calendar yet
Trials studying HYDROCODONE BITARTRATE AND ACETAMINOPHEN
- phase3A Study Evaluating the Efficacy and Safety of Obinutuzumab in Participants With Primary Membranous Nephropathy
- phase1A Research Study Looking Into How NNC0662-0419 Works With Birth Control Pills and Emptying of the Stomach in Women Not Able to Become Pregnant With Excess Body Weight
- phase3A Study of Combogesic® IV (Intravenous) in Pediatric Patients With Acute Pain
- phase3A Clinical Trial of MK-1045 in People With B-cell Acute Lymphoblastic Leukemia (MK-1045-005)
- phase3Sacituzumab Tirumotecan (MK-2870) Versus Pemetrexed and Carboplatin Combination Therapy in Participants With Epidermal Growth Factor (EGFR)-Mutated, Advanced Nonsquamous Non-small Cell Lung Cancer (NSCLC) Who Have Progressed on Prior EGFR Tyrosine Kinase Inhibitors (MK-2870-009)
- phase2A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescents With Active Class III or IV Lupus Nephritis and the Safety and PK of Obinutuzumab in Pediatric Participants
- phase3A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
- phase3SC Versus IV Isatuximab in Combination With Pomalidomide and Dexamethasone in RRMM
News(5)
- Trump's FDA pick Heidi Overton calls vaccines, mifepristone safe and effective in confirmation hearingThe Senate Committee on Health, Education, Labor and Pensions (HELP) today questioned Heidi Overton, M.D., Ph.D., Trump’s pick for FDA commissioner, in a hearing marked by tightrope-walking on issu…fiercebiotech · 10d ago
- Kennedy announces new effort to speed up autism diagnosesHealth secretary Kennedy announced a new effort to improve autism diagnoses, arguing that the current model is outdatedstat · 17d ago
- ARPA-H launches SPECTRA program, new autism research initiativeResearchers will create an end-to-end system to identify ASD risk factors, connect patients to appropriate interventions and accelerate clinical research for new therapies.fiercebiotech · 17d ago
- STAT+: TrumpRx adds generic drugsA deal with Mark Cuban, Amazon Pharmacy, and GoodRx is boosting TrumpRx's offerings.stat · 4mo ago
- STAT+: In her own words: Surgeon general nominee Nicole Saphier expresses enthusiasm and caution for MAHAExamining the past statements and writings of Trump's third surgeon general nominee, Dr. Nicole Saphier, on vaccines, autism, peptides, diet and more.stat · 5mo ago
Data sources
last refreshed 2h ago
Found something off?
comments(0)
5-min edit window · permanent after that